ICH Location May Guide Secondary Prevention Strategy

A new study shows different risks for future cardiovascular events in patients with lobar and non-lobar intracerebral hemorrhage.

Related Keywords

New York ,United States ,Denmark ,Odense ,Syddanmark ,Edinburgh ,City Of ,United Kingdom ,British ,Danish ,Magdy Selim ,Rustam Al Shahi Salman ,David Gaist ,Bristol Myers Squibb ,Recursion Pharmaceuticals Consultancy ,University Of Edinburgh ,British Heart Foundation ,National Institute Of Neurological Disorders ,Odense University Hospital ,Novo Nordisk Foundation ,Pfizer ,Danish National Patient Registry ,Danish Stroke Registry ,Weill Cornell Medicine ,New York City ,Novo Nordisk ,National Institute ,Neurological Disorders ,Bioxodes Consultancy ,Stroke ,Erebrovascular Accident ,Va Cerebrovascular Accident ,Thromboembolism ,Brain Hemorrhage ,Brain Bleeding ,Leeding Brain ,Intracerebral Hemmorhage ,Antithrombotics ,Anti Thrombotics ,Antithrombotic Therapy ,Antithrombotic Agents ,Hemorrhage ,Bleeding ,Ischemic Stroke ,Atrial Fibrillation ,F Atrial Fibrillation ,Traumatic Brain Injury ,Bi Traumatic Brain Injury ,Statin ,Ipid Lowering Dru ,